Abstract
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "GBP1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Wnt/β-catenin signaling pathway, by J. Song, Q.-Y. Wei, published in Eur Rev Med Pharmacol Sci 2020; 24 (10): 5465-5472-DOI:10.26355/eurrev_202005_21331-PMID: 32495881" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/21331.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European review for medical and pharmacological sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
